![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 15, 2015 4:03:36 PM
That said, I do disagree with others here about the presentation. I think the new doc was very low key and did not adequately explain the significance of the spleen tumor almost disappearing, nor did he explain the patient's not continuing in the trial very well.
Agree with you on that, and moreover this (your) explanation would have been much better received and understood by investors, myself included:
"The great reduction in a metastatic spleen tumor caused by ovarian cancer, after only 6 doses of Kevetrin, is something that is almost unheard of. We regret that the patient made what we believe to be a bad choice on the basis of a 10% increase in one CA-125 test, a test which is notoriously unreliable and which can show increases for reasons that are unrelated to cancer recurring. We had felt that her best chance would have been to continue in further trials of Kevetrin, but we hope that the positive effects from her participation in our trial have helped her, and hope that she will continue to improve."
I'm sure he would do great at a more scientific conference, but Leo should probably have given the entire presentation himself as he is a very effective communicator with the general public.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM